The Case for Hormone Replacement: New Studies That Should Inform the Debate.
From: Section of Women’s Health, Women’s Health Center, The Cleveland Clinic Foundation, OH 44195, USA. thackeh@ccf.org
Cleveland Clinic journal of medicine
- Publish Date: Sep 2002
- ISSN: 0891-1150
- Volume: 69
- Issue: 9
- Pages: 670, 672-3, 677-8
- Medium: Print
- Language: English
- Citation (JAMA): Thacker Holly L, et al. The Case for Hormone Replacement: New Studies That Should Inform the Debate.. Sep 2002;69:670, 672-3, 677-8
Abstract
The Women’s Health Initiative found that the risks of hormone replacement therapy (HRT) exceeded its benefits in a large group of older postmenopausal women, but did not consider the efficacy of HRT in relieving vasomotor symptoms. Another recent study found that low-dose HRT was as effective as standard-dose HRT while causing fewer side effects. Smaller studies suggest that HRT may improve depression. HRT is not to be used for cardiovascular risk reduction. Genetic testing may point the way to more rational use of HRT.
Mesh Headings (Keywords): Aged, Breast Neoplasms, Clinical Trials as Topic, Coronary Artery Disease, Depression, Estrogens, Conjugated (USP), Female, Hormone Replacement Therapy, Humans, Medroxyprogesterone 17-Acetate, Menopause, Middle Aged, Risk Assessment, Risk Factors
Check for Full Text / PubMed Unique Identifier (PMID): 12222970
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.